TraceLink Named a Top 10 Pharma and Life Sciences Technology Solution Provider by CIOTechOutlook

January 30, 2025 02:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

BOSTON, Jan. 29, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOTechOutlook as one of the Top 10 Pharma and Life Sciences Technology Solution Providers. This accolade highlights TraceLink's significant role in driving the digital transformation of pharmaceutical supply chains and enhancing patient safety worldwide.

With OPUS, the Orchestration Platform for Universal Solutions, TraceLink is redefining how Life Sciences and Healthcare companies approach end-to-end supply chain digitalization. Supply chains face challenges like inaccurate forecasting, poor inventory management, delayed deliveries, and limited visibility, worsened by fragmented systems, compliance demands, and evolving commerce. As the only no-code network digitalization platform designed to democratize access to end-to-end supply chain integration and orchestration, OPUS empowers supply chain leaders to achieve radical business benefits such as lower out-of-stock, freeing up working capital, and improved operational efficiency.

"This recognition reflects the progress we're making in transforming supply chains into dynamic, patient-focused ecosystems," said Shabbir Dahod, President and CEO of TraceLink. "For CIOs, our platform is a game-changer, simplifying the complexities of global supply chains by enhancing compliance, collaboration, and operational efficiency. Real-time data fuels AI/ML models, and by enabling companies to create clean, real-time data sets, we empower them to innovate, protect patient well-being, and achieve impactful business results."

CIOTechOutlook recently sat down with CEO Shabbir Dahod to gain insights from his two-decade career and hear his perspectives on the future of global supply chains. In the interview, Dahod shares his vision for how advancements in digital networks, predictive analytics, and AI-powered orchestration are set to revolutionize the industry, enabling unprecedented levels of collaboration and transparency. The full interview can be read here.

TraceLink anticipates further innovation in the coming year, including the release of AI-powered supply chain orchestration agents which will accelerate customers' business performance using the growing volume of real-time, end-to-end supply chain transactions and track-and-trace orchestration data flowing through the TraceLink Network.

"TraceLink's solutions are empowering given the complex nature of global pharmaceutical supply chains," said Sudhakar Singh, Editor, CIOTechOutlook. "Its solutions ensure a smooth collaboration between the stakeholders like manufacturers, distributors, and healthcare providers. The connectivity makes it easier to conduct business more coherently even as the supply chain challenges evolve."

About TraceLink:
TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely.

About CIOTechOutlook:
CIOTechOutlook is one of the largest publications focusing on the IT industry, created specifically for Chief Information Officers (CIOs) and IT Heads. It is a forum for the luminaries of the industry to share their profound insights, viewpoints, and experiences in the fast-changing area of information technology with a wide audience of enterprise decision makers.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.